INS and diabetes mellitus: The majority of patients were taking metformin in combination with sulfonylurea and were also using a short- and long-acting (Actrapid-Insulatard) insulin combination or an insulin analog (Apidra-Lantus) combination, which was likely due to the presence of a government diabetes program and a free drug provision program [26].